This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
protein
product name :
Human PLEKHA7 (aa 714-820) Control Fragment Recombinant Protein
catalog :
RP-108512
quantity :
100 uL
price :
US 259.00
product information
Product Type :
Protein
Product Name :
Human PLEKHA7 (aa 714-820) Control Fragment Recombinant Protein
Catalog # :
RP-108512
Quantity :
100 uL
Price :
US 259.00
Clonality :
Recombinant
Purity :
purified
Reactivity :
Human
Applications :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Species :
Human
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
PLEKHA7 is required for zonula adherens biogenesis and maintenance. Acts via its interaction with KIAA1543/Nezha, which anchors microtubules at their minus-ends to zonula adherens, leading to the recruitment of KIFC3 kinesin to the junctional site.
Format :
Liquid
Applications w/Dilutions :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Aliases :
A430081P20Rik; AI414265; DKFZp686M22243; Hadp1; Heart adapter protein 1; PH domain-containing family A member 7; PH domain-containing family A member 7 antibody; pleckstrin homology domain containing A7; pleckstrin homology domain containing A7 antibody; pleckstrin homology domain containing, family A member 2; pleckstrin homology domain containing, family A member 7; pleckstrin homology domain-containing family A member 7; Plekha7
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments